SIR2026: Neurointerventional Radiology

Expand your expertise in the minimally invasive treatment of cerebrovascular disease, stroke, aneurysms, vascular malformations, and spinal interventions. Learn evolving techniques, device innovations, and evidence-based approaches to neurovascular care.

Course summary
Available credit: 
  • 2.75 AMA PRA Category 1 Credit
  • 2.75 Participation
Course opens: 
07/31/2026
Course expires: 
12/31/2027
Cost:
$0.00

Click here for Financial Disclosures

Purpose/Desired Learning Outcome 
Following this activity, learners will be better able to apply current evidence and advanced neurointerventional techniques to improve the diagnosis and treatment of cerebrovascular disease.

Accreditation Statement
The Society for Interventional Radiology (SIR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Society for Interventional Radiology (SIR) designates this Live Activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Claiming CME

  • Attend the sessions in full for which credit is sought
  • Complete the post-activity evaluation
  • A certificate of completion/transcript will be available once the evaluation is submitted

Disclosure of Commercial Support

The Society for Interventional Radiology (SIR) received funding to support the live meeting where these sessions were recorded from:

  • Abbott
  • BD
  • Boston Scientific
  • Cook
  • Cordis
  • GE HealthCare
  • Gore
  • Guerbet
  • Sirtex

Bibliography

References are in the slides.

Launch Date: August 1, 2026

Last Review Date:

Expiration Date: December 31, 2027

Available Credit

  • 2.75 AMA PRA Category 1 Credit
  • 2.75 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Click the green "Take Course" button to get started.

Required Hardware/software

Google Chrome is the preferred web browser.